Hemant Surgical Industries secures ₹264 Cr order from Ministry of Health

Synopsis: Healthcare stock rises 6.93% after securing a Rs 264 crore government order from CMSS for medical equipment, boosting market focus and interim supply commencement.

The shares of this company, which operates in B2B healthcare, importing, manufacturing, assembling, and marketing products to medical facilities today, came into focus after a significant order from the Government of India (CMSS)

With a market capitalization of Rs 401.58 crore, Hemant Surgical Industries Ltd’s shares on Wednesday made a day high of Rs 323 per share, up by 6.93 percent from the previous day’s close price of Rs 302.05per share. The share of the company trades at a fairly high P/E of 39.3x compared to the industry P/E of 37.6x.

Significant Order

Hemant Surgical Industries Ltd received a purchase order of Rs 264.33 from Central Medical Service Society, Ministry of Health and Family Welfare, Government of India(CMSS), for the supply of medical equipment to be executed in tranches by September 30, 2026.

The PO includes the supply of a Flat Panel Detector with two batteries and a router, a hard travel case, other utilities, and an X-Ray Generator. While final commercial terms and the delivery schedule are still under discussion, the company has agreed to commence interim supplies, considering the national importance of the project and CMSS’s request.

As of September 2025, the shareholding pattern shows the promoter stake decreased from 73.56% in September 2024 to 58.90%. FIIs increased from to 0.15%, while DIIs rose from 1.13% to 10.81%. The public holding also grew from 25.31% last year to 30.13%, reflecting a notable diversification of the shareholding base.

Hemant Surgical Industries Limited (HSIL), established in 1989 and based in Mumbai, is a prominent manufacturer, importer, and exporter of medical equipment and surgical disposables, including renal care, cardiovascular, and critical care products. They are the exclusive importer for JMS Co. Ltd., Japan, and produce items like dialysis machines, nebulizers, and surgical disposables under the ‘AERO’ brand.

Financial Highlights: The revenue from operations grew by 30.6%  from Rs 49 crore in H1 FY25 to Rs 64 crore in H1 FY26. Accompanied by net profit growth of 66% to Rs 5 crore in H1 FY26 from Rs 3 crore in H1 FY2,5 and EPS grew by 36% to Rs 4.15 per share in H1 FY26 from Rs 3.05 per share in H1 FY25.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Hemant Surgical Industries secures ₹264 Cr order from Ministry of Health appeared first on Trade Brains.